Literature DB >> 28333690

Diagnosis and evaluation of hyperbilirubinemia.

Jeremy I Sullivan1, Don C Rockey.   

Abstract

PURPOSE OF REVIEW: Jaundice, the physical finding associated with hyperbilirubinemia, results when the liver is unable to properly metabolize or excrete bilirubin. The purpose of this review is to examine some of the most common causes of jaundice in adults, provide insight into the diagnostic evaluation of jaundice, and review information on the outcomes of patients with jaundice. RECENT
FINDINGS: An elevated level of bilirubin almost always indicates the presence of an underlying disease state. The best approach to evaluating a patient with jaundice is to start with a careful history and physical examination, followed by imaging assessment of the biliary tree and liver. There are algorithm models that incorporate bilirubin levels in their predictor models for outcomes in patients with chronic liver disease (i.e., the model for end-stage liver disease). However, there are few studies that have examined the outcomes of patients with jaundice.
SUMMARY: Evaluation of patients with jaundice starts with a careful history and physical examination, followed by directed imaging of the biliary tree and liver. Although jaundice is generally believed to be a serious medical condition, there is little literature that addresses outcomes in patients with jaundice.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28333690     DOI: 10.1097/MOG.0000000000000354

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  12 in total

Review 1.  How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysis.

Authors:  Alessandro Rizzo; Angela Dalia Ricci; Giorgio Frega; Andrea Palloni; Stefania DE Lorenzo; Francesca Abbati; Veronica Mollica; Simona Tavolari; Mariacristina DI Marco; Giovanni Brandi
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  A Clinically Practical and Interpretable Deep Model for ICU Mortality Prediction with External Validation.

Authors:  Yanni Kang; Xiaoyu Jia; Kaifei Wang; Yiying Hu; Jianying Guo; Lin Cong; Xiang Li; Guotong Xie
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

Review 3.  Hyperbilirubinemia, Hypertension, and CKD: the Links.

Authors:  Ibrahim Mortada
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

4.  Murine epithelial sodium (Na+) channel regulation by biliary factors.

Authors:  Xue-Ping Wang; Seohyun Janice Im; Deidra M Balchak; Nicolas Montalbetti; Marcelo D Carattino; Evan C Ray; Ossama B Kashlan
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

5.  An ultrasound-based approach to jaundice from diagnosis to treatment.

Authors:  Gianpaolo Vidili; Marco Arru; Beatrice Solinas; Davide Turilli
Journal:  Intern Emerg Med       Date:  2022-10-22       Impact factor: 5.472

6.  Baicalin Suppresses Bilirubin-Induced Apoptosis and Inflammation by Regulating p38 Mitogen-Activated Protein Kinases (MAPK) Signaling in Neonatal Neurons.

Authors:  Shuang Shi; Qianwei Cui; Jing Xu; Zhiguo Tang; Binya Shi; Zhongwei Liu
Journal:  Med Sci Monit       Date:  2020-07-07

7.  Predictive value of different bilirubin subtypes for clinical outcomes in patients with acute ischemic stroke receiving thrombolysis therapy.

Authors:  Qiwei Peng; Rentang Bi; Shengcai Chen; Jiefang Chen; Zhifang Li; Jianzhuang Li; Huijuan Jin; Bo Hu
Journal:  CNS Neurosci Ther       Date:  2021-11-14       Impact factor: 5.243

8.  Protective Effects of Chitosan-Bilirubin Nanoparticles Against Ethanol-Induced Gastric Ulcers.

Authors:  Zhiwei Huang; Yannan Shi; Hengcai Wang; Changju Chun; Longwang Chen; Kang Wang; Zhongqiu Lu; Yingzheng Zhao; Xinze Li
Journal:  Int J Nanomedicine       Date:  2021-12-20

9.  Transiently Elevated TC and sdLDL-C Levels and Falsely Low LDL-C Levels in Patients with Extrahepatic Cholangiocarcinoma.

Authors:  Yi Guo; Yong-Gen Zhang; Hong-Chun Li; Yin-Hai Xu
Journal:  Onco Targets Ther       Date:  2021-02-15       Impact factor: 4.147

10.  The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach.

Authors:  Lenka N C Boyd; Mahsoem Ali; Laura Kam; Jisce R Puik; Stephanie M Fraga Rodrigues; Eline S Zwart; Freek Daams; Barbara M Zonderhuis; Laura L Meijer; Tessa Y S Le Large; Elisa Giovannetti; Hanneke W M van Laarhoven; Geert Kazemier
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.